[{"id":"northwest-biotherapeutics","kind":"company","name":"Northwest Biotherapeutics","route":"/companies/northwest-biotherapeutics/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/spikes/glioblastoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://nwbio.com\" }]"}]},{"id":"northwest-biotherapeutics","kind":"company","name":"Northwest Biotherapeutics","route":"/companies/northwest-biotherapeutics/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/spikes/glioblastoma.ts","type":"changed","fields":[{"field":"tldr","before":"\"Developer of the DCVax-L dendritic cell vaccine for glioblastoma, seeking UK approval on contested phase 3 data.\"","after":"\"Northwest Biotherapeutics developed the DCVax-L dendritic cell vaccine for glioblastoma and is seeking UK approval on contested phase 3 data.\""}]}]